Deutsche Bank Ag\ Royalty Pharma PLC Transaction History
Deutsche Bank Ag\
- $248 Billion
- Q4 2024
A detailed history of Deutsche Bank Ag\ transactions in Royalty Pharma PLC stock. As of the latest transaction made, Deutsche Bank Ag\ holds 3,189,964 shares of RPRX stock, worth $104 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,189,964
Previous 2,342,260
36.19%
Holding current value
$104 Million
Previous $66.3 Million
22.81%
% of portfolio
0.03%
Previous 0.03%
Shares
18 transactions
Others Institutions Holding RPRX
# of Institutions
431Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.29 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.22 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$754 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$556 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$463 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.3B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...